SCHEMBL21381473

SCHEMBL21381473

Cc1[c]cc(-c2ccc(C3CC3)cc2)n1Cc1ccc2c(c1)OCO2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV6 Q9H1D0 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.45
▸ MAPT P10636 3/20 0.45
▸ TSHR P16473 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ LMNA P02545 2/20 0.44
▸ CMA1 P23946 1/20 0.40
▸ THRB P10828 2/20 0.39
▸ EDNRB P24530 2/20 0.39
▸ EDNRA P25101 2/20 0.39
▸ PDE1A P54750 2/20 0.39
▸ PDE1B Q01064 2/20 0.39
▸ PDE1C Q14123 2/20 0.39
▸ MCHR1 Q99705 1/20 0.38
▸ CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20379417 0.88 SMN1; SMN2 (0.54) SIGMAR1MAPTTSHRKDM4EMEN1
SCHEMBL21381476 0.86 SMN1; SMN2 (0.53) MAPTTSHRKDM4EMEN1CASP1
SCHEMBL20379410 0.85 SMN1; SMN2 (0.53) MAPTTSHRKDM4EMEN1CASP1
SCHEMBL21381478 0.85 THRB (0.52) SIGMAR1MAPTTSHRKDM4EMEN1
SCHEMBL20379084 0.85 MAPT (0.47) SIGMAR1MAPTTSHRKDM4EMEN1
SCHEMBL28331412 0.83 TRPV6 (0.48) TRPV6SIGMAR1MAPTTSHRKDM4E
SCHEMBL21373574 0.83 SMN1; SMN2 (0.47) MAPTTSHRKDM4EMEN1CASP1
SCHEMBL20379088 0.82 TSHR (0.50) TRPV6SIGMAR1MAPTTSHRKDM4E
SCHEMBL21373558 0.79 BRD9 (0.40) TRPV6MAPTTSHRKDM4ECMA1
SCHEMBL20379164 0.78 TRPV6 (0.47) TRPV6SIGMAR1MAPTTSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3768673-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH Zurich (CH) 2021-01-27 — — EP claimed
WO-2019179890-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH ZURICH (CH) 2019-09-26 — — WO claimed
EP-3768673-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH Zurich (CH) 2021-01-27 — — EP disclosed
WO-2019179890-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH ZURICH (CH) 2019-09-26 — — WO disclosed
Send feedback